levofloxacin has been researched along with bromodeoxyuridine in 2 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (bromodeoxyuridine) | Trials (bromodeoxyuridine) | Recent Studies (post-2010) (bromodeoxyuridine) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 13,164 | 71 | 1,816 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawahara, K; Kitajima, I; Maruyama, I; Nakata, M; Yamakuchi, M | 1 |
| Bravos, PD; Frenkel, B; Holtom, PD; Patzakis, MJ; Pavkovic, SA; Shepherd, LE | 1 |
2 other study(ies) available for levofloxacin and bromodeoxyuridine
| Article | Year |
|---|---|
New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines.
Topics: Anti-Infective Agents; Bromodeoxyuridine; Carcinoma, Transitional Cell; Cell Cycle; DNA, Neoplasm; Humans; Levofloxacin; Ofloxacin; Telomerase; Tumor Cells, Cultured | 1997 |
Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro.
Topics: Animals; Anti-Infective Agents; Bromodeoxyuridine; Calcification, Physiologic; Cell Count; Cell Division; Cells, Cultured; Ciprofloxacin; Dose-Response Relationship, Drug; Extracellular Matrix; Fluoroquinolones; Levofloxacin; Mice; Naphthyridines; Ofloxacin; Osteoblasts | 2000 |